Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Azathioprine: Sample

Download as pdf or txt
Download as pdf or txt
You are on page 1of 7
At a glance
Powered by AI
The documents discuss various methods for extracting and analyzing azithromycin from different biological samples like serum and tissues using liquid chromatography with electrochemical detection.

Serum and tissues like blood, brain, muscle, liver and kidney are some of the sample matrices discussed for analysis.

Liquid chromatography with electrochemical detection is the main analytical technique used. Sample preparation involves liquid-liquid or solid phase extraction followed by chromatographic separation and detection.

Previous page

Azathioprine
Molecular formula: C9H7N7O2S
Molecular weight: 277.3
CAS Registry No.: 446-86-6

SAMPLE
Matrix: blood
Sample preparation: 500 fxL Serum + 25 ng 9-methylazathioprine + 4.5 mL ethyl acetate,
vortex for 1 min, centrifuge for 1 min, repeat extraction. Combine the organic layers and
evaporate them to dryness under reduced pressure at 35°, reconstitute the residue in 250
IxL mobile phase, vortex for 10 s, sonicate for 10 min, inject a 200 |xL aliquot.

HPLCVARIABLES
Guard column: 4 X 4.6 5 |xm LiChrospher 100 RP 18
Column: 250 X 4.6 5 jxm LiChrospher 60 Rp-select B
Mobile phase: MeCN: 10 mM pH 2.3 potassium phosphate buffer 12:88 (Flush with
MeCN: buffer 50:50 for 2 min after each run.)
Column temperature: 22
Flow rate: 1
Injection volume: 200
Detector: UV 285

CHROMATOGRAM
Retention time: 16
Internal standard: 9-methylazathioprine (Add 400 mg anhydrous potassium carbonate
and 200 \xL methyl iodide to a solution of 220 mg azathioprine in 7 mL DMF at 0-5°, stir
under nitrogen for 24 h, add 14 mL water, neutralize with 1 M HCl and sodium bicar-
bonate solution, filter, wash the solid with water, dry under vacuum to give 9-methyla-
zathioprine (mp 174-5°). Purify by precipitating from DMF solution with water.) (29)
Limit of quantitation: 2.5 ng/mL

OTHER SUBSTANCES
Noninterfering: 6-mercaptopurine

KEYWORDS
serum; pharmacokinetics

REFERENCE
Binscheck, T.; Meyer, H.; Wellhomer, H.H. High-performance liquid chromatographic assay for the mea-
surement of azathioprine in human serum samples. J.Chromatogr.B, 1996, 675, 287-294

SAMPLE
Matrix: blood
Sample preparation: Condition a 100 mg Isolute C8 SPE cartridge (International Sorbent
Technology) with 2.5 mL MeOH and 3.5 mL 10 mM pH 7.0 phosphate buffer. 1 mL Plasma
+ 50 |xL 1.5 |xg/mL guaneran + 2 mL 10 mM pH 7.0 phosphate buffer, mix, add to the
SPE cartridge at 2.5 mL/min, wash with 3 mL MeCN :pH 7.0 phosphate buffer 1:99, air
dry for 2 min, elute with 2 mL MeOH: ethyl acetate 5:95. Evaporate the eluate to dryness
under a stream of nitrogen at 40°, reconstitute the residue in 50 |xL mobile phase, inject
a 20 |xL aliquot.
HPLCVARIABLES
Column: 80 X 4.6 3 [Lm HSpecosphere 3CR C8 (Perkin-Elmer)
Mobile phase: MeCN: 10 mM pH 6.2 sodium phosphate buffer 9:91
Flow rate: 1.2
Injection volume: 20
Detector: UV 280

CHROMATOGRAM
Retention time: 8.9
Internal standard: guaneran (6-[(l-methyl-4-nitro-5-imidazolyl)thio]-2-aminopurine, Well-
come Foundation) (7.7)
Limit of detection: 0.5 ng/mL

OTHER SUBSTANCES
Simultaneous: caffeine
Noninterfering: aspirin, chloroquine, cyclosporin, diltiazem, nifedipine, prednisolone

KEYWORDS
plasma; pharmacokinetics; SPE
REFERENCE
Albertioni, R; Pettersson, B.; Ohlman, S.; Peterson, C. Analysis of azathioprine and 6-mercaptopurine
in plasma in renal transplant recipients after administration with oral azathioprine. J.Liq.
Chromatogr., 1995, 18, 3991-4005

SAMPLE
Matrix: blood
Sample preparation: Condition a 1 mL Sep-Pak silica SPE cartridge with 3 mL ethyl
acetate and vacuum dry for 1 min. 1 mL Plasma + 2.8 [xg antipyrine, add to SPE car-
tridge, wash with 5 mL benzene (Caution! Benzene is a carcinogen!) or hexane over 1
min, vacuum dry for 1 min, elute with 5 mL ethyl acetate. Evaporate the eluate to dryness
under a stream of nitrogen, reconstitute the residue in 200 |JLL mobile phase, sonicate,
inject all of the sample.

HPLCVARIABLES
Guard column: C18 Guard-Pak (Waters)
Column: 100 X 8 4 |xm 8 NV C18 Radial-Pak (Waters)
Mobile phase: MeOH .10 mM pH 4.5 sodium phosphate 13:87
Flow rate: 3
Injection volume: 200
Detector: UV 280

CHROMATOGRAM
Retention time: 7
Internal standard: antipyrine (17)
Limit of quantitation: 5 ng/mL

OTHER SUBSTANCES
Simultaneous: acetaminophen, aspirin, carmustine, chlorambucil, cytarabine, dacarba-
zine, diclofenac, etoposide, 5-fluorouracil, ifosfamide, indomethacin, lomustine, metho-
trexate, naproxen, salicylic acid, tegafur, teniposide, thioguanine
Noninterfering: betamethasone, carboplatin, cyclophosphamide, cyclosporine A, ibuprofen,
thiotepa

KEYWORDS
plasma; rabbit; SPE; human; pharmacokinetics
REFERENCE
el-Yazigi, A.; Abdel Wahab, F. Expedient liquid chromatographic analysis of azathioprine in plasma by
use of silica solid phase extraction. Ther.Drug Monit, 1992, 14, 312-316

SAMPLE
Matrix: blood
Sample preparation: 200 u,L Serum + 5 uJL 50 |xg/mL 2-ethyl-4-oxoquinazoline in EtOH
+ 100 \xL reagent, let stand at room temperature for 1 h, add 1.8 mL ethyl acetate, mix,
centrifuge at 1800 g for 5 min, remove 1.5 mL of the supernatant, repeat the extraction.
Combine the organic layers and evaporate them to dryness under reduced pressure below
30°, reconstitute the residue in 100 |xL initial mobile phase, inject a 90 |xL aliquot. (Re-
agent was 30 mg N-ethylmaleimide in 2 mL 50 mM pH 7.0 phosphate buffer, prepare
fresh daily.)

HPLCVARIABLES
Column: 10 |xm ixBondapak C18
Mobile phase: Gradient. MeCN: 10 mM KH2PO4 9:91 for 26 min, then 50:50 for 1 min
(step gradient).
Flow rate: 1.5
Injection volume: 90
Detector: UV 280

CHROMATOGRAM
Retention time: 13.4
Internal standard: 2-ethyl-4-oxoquinazoline (28)
Limit of quantitation: 10 ng/mL

OTHER SUBSTANCES
Extracted: 6-mercaptopurine

KEYWORDS
serum
REFERENCE
Tsutsumi, K.; Otsuki, Y; Kinoshita, T. Simultaneous determination of azathioprine and 6-mercaptopu-
rine in serum by reversed-phase high-performance liquid chromatography. J.Chromatogr., 1982,231,
393-399

SAMPLE
Matrix: formulations
Sample preparation: Dissolve crushed tablets or the freeze-dried compound for injection
in 20 mM NaOH. Add a 10 mL aliquot of this solution (or a saline injection) to 10 mL 3
mg/mL theophylline in 20 mM NaOH, inject a 1.5 |xL aliquot.

HPLCVARIABLES
Column: 100 X 5 5 |xm ODS-Hypersil
Mobile phase: MeOH: 25 mM KH2PO4: glacial acetic acid 20:79:5 adjusted to pH 4.50
(Flush column with MeOH: water 60:40 at the end of each day.)
Flow rate: 1.5
Injection volume: 1.5
Detector: UV 240

CHROMATOGRAM
Retention time: 4.2
Internal standard: theophylline (3.5)
OTHER SUBSTANCES
Simultaneous: impurities, degradation products, 6-mercaptopurine

KEYWORDS
stability-indicating; injections; tablets

REFERENCE
Fell, A.F.; Plag, S.M.; Neil, J.M. Stability-indicating assay for azathioprine and 6-mercaptopurine by
reversed-phase high-performance liquid chromatography. J.Chromatogr., 1979, 186, 691-704

• • •
ANNOTATED BIBLIOGRAPHY
Ding, T.L.; Benet, L.Z. Determination of 6-mercaptopurine and azathioprine in plasma by high-perfor-
mance liquid chromatography. J.Chromatogr., 1979, 163, 281-288
Azithromycin
Molecular formula: C38H72N2O12
Molecular weight: 749.0
CAS Registry No.: 83905-01 -5

SAMPLE
Matrix: blood
Sample preparation: 50 |xL Serum + 50 jxL 60 mM potassium carbonate + 50 |xL 50
ng/mL IS in MeCN water 50:50, mix, add 200 |JLL water, vortex for several s, add 3 mL
MTBE, vortex for 20 s, centrifuge at 3300 rpm for 3 min. Remove the organic layer and
evaporate it to dryness in a vortex evaporator at 40°, reconstitute the residue in 100 jxL
mobile phase, sonicate, vortex, inject a 50 |xL aliquot.

HPLCVARIABLES
Column: 30 X 4.6 3 |xm Hypersil ODS
Mobile phase: MeCN: MeOH: THF: 50 mM ammonium acetate 44:19:3:34
Flow rate: 1
Injection volume: 50
Detector: MS, SCIEX API III, atmospheric pressure ionization, nebulizer probe 450°, 2.5
|xA Corona discharge needle, quadrupole mass filter, 0.002 inch pinhole aperture, SIM
m/z 749 and 752

CHROMATOGRAM
Retention time: 1.9
Internal standard: trideuteroazithromycin
Limit of quantitation: 10 ng/mL

KEYWORDS
serum

REFERENCE
Fouda, H.G.; Schneider, R.P. Quantitative determination of the antibiotic azithromycin in human serum
by high-performance liquid chromatography (HPLC)-atmospheric pressure chemical ionization mass
spectrometry: Correlation with a standard HPLC-electrochemical method. Ther.Drug Monit., 1995,
17, 179-183

SAMPLE
Matrix: blood
Sample preparation: 1 mL Serum + 25 JULL 10 |xg/mL IS in MeCN + 1 mL 30 mM potas-
sium carbonate, vortex, add 5 mL MTBE, vortex for 30 s, centrifuge at 2000 g for 10 min.
Remove the organic layer and evaporate it to dryness under vacuum at 37°, reconstitute
the residue in 300 |xL mobile phase, vortex for 30 s, add 1 volume hexane, vortex, cen-
trifuge, remove the aqueous layer, inject a 50 jxL aliquot of the aqueous layer (J. Chro-
matogr. 1991, 565, 321).

HPLCVARIABLES
Guard column: 20 X 4.6 5 \xm Nucleosil C18
Column: 125 X 4.6 5 |xm Nucleosil C18
Mobile phase: MeCN: 40 mM Na2HPO4:5 mM tetrabutylammonium phosphate 33:50:50,
adjusted to pH 7.0 with 25% phosphoric acid
Flow rate: 1
Injection volume: 50
Detector: E, ESA 5100A Coulochem, guard cell +1 V, dual electrode analytical cell +0.7
and +0.8 V

CHROMATOGRAM
Retention time: 5.8
Internal standard: n-propyl analog of azithromycin (7.8)
Limit of quantitation: 8 ng/mL

OTHER SUBSTANCES
Extracted: metabolites

KEYWORDS
serum; pharmacokinetics

REFERENCE
Riedel, K.-D.; Wildfeuer, A.; Laufen, H.; Zimmermann, T. Equivalence of a high-performance liquid
chromatographic assay and a bioassay of azithromycin in human serum samples. J.Chromatogr.,
1992, 576, 358-362

SAMPLE
Matrix: blood
Sample preparation: 1 mL Serum -h 25 |ULL 10 jutg/mL IS in MeCN + 1 mL 30 mM potas-
sium carbonate, vortex, add 5 mL MTBE, vortex for 30 s, centrifuge at 2000 g for 10 min.
Remove the organic layer and evaporate it to dryness under vacuum at 37°, reconstitute
the residue in 300 |xL mobile phase, vortex for 30 s, add 1 volume hexane, vortex, cen-
trifuge, remove the aqueous layer, inject a 100 JJLL aliquot of the aqueous layer.

HPLCVARIABLES
Guard column: 21 X 3 40 |xm glass bead column (Waters)
Column: 50 X 4.6 5 |xm Chromegabond alkylphenyl (ES Industries)
Mobile phase: MeCN:MeOH:20 mM ammonium acetate:20 mM sodium perchlorate 45:
10:22:23, adjust apparent pH to 6.8-7.2 with glacial acetic acid
Flow rate: 1
Injection volume: 100
Detector: E, ESA 5100A Coulochem, ESA 5020 guard cell +1V, ESA 5010 dual electrode
analytical cell, screen electrode +0.7 V, detector electrode +0.8 V, porous carbon electrodes

CHROMATOGRAM
Retention time: 9
Internal standard: 9a-N-propyl analog of azithromycin (13)
Limit of quantitation: 10 ng/mL

OTHER SUBSTANCES
Extracted: metabolites

KEYWORDS
serum; human; mouse; rat; dog; rabbit

REFERENCE
Shepard, R.M.; Duthu, G.S.; Ferraina, RA.; Mullins, M.A. High-performance liquid chromatographic
assay with electrochemical detection for azithromycin in serum and tissues. J.Chromatogr., 1991,
565, 321-337
SAMPLE
Matrix: blood, tissue
Sample preparation: Serum. 500 JXL Serum + 25 |xL 2 [xg/mL IS in MeCN + 500 |JLL 60
mM potassium carbonate, vortex, add 5 mL MTBE, vortex for 30 s, centrifuge at 2000 g
for 10 min. Remove the organic layer and add it to 500 JJLL 15 mM pH 3.1 citric acid,
vortex for 30 s, centrifuge at 2000 g for 5 min. Remove the aqueous layer and add it to
1 mL 60 mM potassium carbonate, vortex for 1 min, add 5 mL MTBE, vortex for 30 s,
centrifuge at 2000 g for 10 min. Remove the organic layer and evaporate it to dryness
under vacuum at 37°, reconstitute the residue in 300 fxL MeCN: water 50:50, vortex for
30 s, add 1 volume hexane, vortex, centrifuge, remove the aqueous layer, inject a 60 JULL
aliquot of the aqueous layer. (For high azithromycin concentrations extraction into citric
acid and back extraction is not necessary.) Tissue. 1 g Tissue + 9 volumes MeCN + 50
IxL 20 fxg/mL IS in MeOH, homogenize (Polytron PT 10/35) for 10 s, centrifuge at 2000 g
for 10 min. Remove a 500 u,L aliquot of the supernatant and evaporate it to dryness
under vacuum at 50°, reconstitute the residue 500 |JLL 60 mM potassium carbonate, add
5 mL MTBE, vortex for 30 s, centrifuge at 2000 g for 10 min. Remove the organic layer
and evaporate it to dryness under vacuum at 37°, reconstitute the residue in 300 |xL
MeCN: water 50:50, vortex for 30 s, add 1 volume hexane, vortex, centrifuge, remove the
aqueous layer, inject a 20-60 |JLL aliquot of the aqueous layer.

HPLCVARIABLES
Guard column: 21 X 3 40 fim glass bead column (Waters)
Column: 150 X 4.6 5 jjim Chromegabond 7-RP-l alumina (ES Industries)
Mobile phase: MeCN: 50 mM potassium phosphate 30:70, adjusted to an apparent pH of
11.0 with 1 M KOH
Flow rate: 1
Injection volume: 60
Detector: E, BAS LC-4B (Bioanalytical Systems), glassy carbon electrode +0.8 V, Ag/AgCl
reference electrode

CHROMATOGRAM
Retention time: 8
Internal standard: 9a-N-propargyl analog of azithromycin (10)
Limit of detection: 100 ng/g (tissue)
Limit of quantitation: 10 ng/mL (serum)

OTHER SUBSTANCES
Extracted: metabolites

KEYWORDS
serum; human; mouse; rat; dog; rabbit; brain; muscle; liver; kidney

REFERENCE
Shepard, R.M.; Duthu, G.S.; Ferraina, R.A.; Mullins, M.A. High-performance liquid chromatographic
assay with electrochemical detection for azithromycin in serum and tissues. J.Chromatogr., 1991,
565, 321-337

You might also like